Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 347,510 | 310,547 | 326,441 | 380,860 | 376,778 |
| Receivables | 23,866 | 24,037 | 72,971 | 23,251 | 20,863 |
| Inventories | 19,428 | 18,250 | 12,073 | 15,745 | 14,650 |
| Other current assets | 22,004 | 27,173 | 23,495 | 18,243 | 12,151 |
| TOTAL | $412,808 | $380,007 | $434,980 | $438,099 | $424,442 |
| Non-Current Assets | |||||
| PPE Net | 5,400 | 4,484 | 3,355 | 3,169 | 3,596 |
| Investments And Advances | 28,322 | 29,533 | 7,613 | 34,687 | 36,817 |
| Intangibles | 13,536 | 13,586 | 0 | 14,598 | 14,575 |
| Other Non-Current Assets | 47,236 | 40,062 | 44,911 | 41,206 | 41,033 |
| TOTAL | $94,494 | $87,665 | $55,879 | $93,660 | $96,021 |
| Total Assets | $507,302 | $467,672 | $490,859 | $531,759 | $520,463 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,861 | 13,533 | N/A | 12,469 | 6,573 |
| Accounts payable and accrued liabilities | 11,691 | 8,694 | 12,351 | 11,611 | 13,019 |
| Accrued Expenses | N/A | N/A | 68,491 | N/A | N/A |
| Other current liabilities | 53,397 | 57,412 | N/A | 62,658 | 52,384 |
| TOTAL | $80,581 | $81,086 | $81,939 | $87,573 | $73,684 |
| Non-Current Liabilities | |||||
| Long Term Debt | 97,356 | 97,011 | 109,714 | 96,731 | N/A |
| Other Non-Current Liabilities | 337,954 | 251,890 | 219,755 | 242,672 | 331,433 |
| TOTAL | $435,310 | $348,901 | $329,469 | $339,403 | $331,433 |
| Total Liabilities | $515,891 | $429,987 | $411,408 | $426,976 | $405,117 |
| Shareholders' Equity | |||||
| Common Shares | 7,312 | 7,312 | 7,312 | 6,699 | 6,445 |
| Retained earnings | -1,187,228 | -1,140,111 | -1,095,419 | -1,056,528 | -1,005,920 |
| Other shareholders' equity | 164,572 | 163,641 | 2,144 | 147,102 | 133,003 |
| TOTAL | $-8,589 | $37,685 | $79,451 | $104,783 | $115,346 |
| Total Liabilities And Equity | $507,302 | $467,672 | $490,859 | $531,759 | $520,463 |